75 related articles for article (PubMed ID: 1628133)
1. Interleukin-2 (IL-2) and IL-2-activated bone marrow in transplantation: evaluation from a clinical perspective.
Charak BS; Agah R; Brynes RK; Chogyoji M; Groshen S; Chen SC; Mazumder A
Bone Marrow Transplant; 1992 Jun; 9(6):479-86. PubMed ID: 1628133
[TBL] [Abstract][Full Text] [Related]
2. Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy.
Charak BS; Brynes RK; Katsuda S; Groshen S; Chen SC; Mazumder A
Cancer Res; 1991 Apr; 51(8):2015-20. PubMed ID: 2009520
[TBL] [Abstract][Full Text] [Related]
3. Potent graft antitumor effect in natural killer-resistant disseminated tumors by transplantation of interleukin 2-activated syngeneic bone marrow in mice.
Agah R; Malloy B; Kerner M; Girgis E; Bean P; Twomey P; Mazumder A
Cancer Res; 1989 Nov; 49(21):5959-63. PubMed ID: 2790810
[TBL] [Abstract][Full Text] [Related]
4. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
Mumcuoglu M; Naparstek E; Slavin S
Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical application.
Charak BS; Areman EM; Dickerson SA; Choudhary GD; Sacher R; Kotula PL; Brown EG; Mazumdar A
Bone Marrow Transplant; 1993 Feb; 11(2):147-54. PubMed ID: 8435664
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 in bone marrow transplantation: preclinical studies.
Charak BS; Choudhary GD; Tefft M; Mazumder A
Bone Marrow Transplant; 1992 Aug; 10(2):103-11. PubMed ID: 1326364
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of IL-2-activated bone marrow cells as a potent graft vs tumor effector in transplantation.
Agah R; Malloy B; Kerner M; Mazumder A
J Immunol; 1989 Nov; 143(9):3093-9. PubMed ID: 2809219
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation.
Kedar E; Tsuberi BZ; Landesberg A; Anafi M; Leshem B; Gillis S; Urdal DL; Slavin S
Bone Marrow Transplant; 1988 Jul; 3(4):297-314. PubMed ID: 3048495
[TBL] [Abstract][Full Text] [Related]
9. Graft versus leukemia effect after transplantation with interleukin-2-activated bone marrow. Correlation with eradication of residual disease.
Charak BS; Brynes RK; Chogyoji M; Kortes V; Tefft M; Mazumder A
Transplantation; 1993 Jul; 56(1):31-7. PubMed ID: 8333064
[TBL] [Abstract][Full Text] [Related]
10. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
[TBL] [Abstract][Full Text] [Related]
11. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to purging of leukemia by activation of bone marrow with interleukin 2.
Charak BS; Malloy B; Agah R; Mazumder A
Bone Marrow Transplant; 1990 Sep; 6(3):193-8. PubMed ID: 2252959
[TBL] [Abstract][Full Text] [Related]
13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
14. Cytokines transduced bone marrow stromal cell lines promote immunohematopoietic reconstitution in mice after allogeneic bone marrow transplantation.
Li A; Jiang J; Zhang Q; Hao J; Xie S
Immunol Lett; 2005 May; 98(2):216-24. PubMed ID: 15860221
[TBL] [Abstract][Full Text] [Related]
15. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.
Varas F; Bernard A; Bueren JA
Exp Hematol; 1998 Feb; 26(2):100-9. PubMed ID: 9472799
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of anti-tumor cytotoxic effectors.
Verma UN; Bagg A; Brown E; Mazumder A
Bone Marrow Transplant; 1994 Feb; 13(2):115-23. PubMed ID: 8205079
[TBL] [Abstract][Full Text] [Related]
17. [Acceleration of hematopoietic reconstitution in mice transplanted with syngeneic bone marrow cells by IL-6 gene therapy].
Cai R; Cao X; Ma S
Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):97-101. PubMed ID: 9206038
[TBL] [Abstract][Full Text] [Related]
18. Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD.
Cooper MH; Patrene KD; Vecchini F; Austin CA; Markus PM; Boggs SS
Bone Marrow Transplant; 1994 Sep; 14(3):355-62. PubMed ID: 7527689
[TBL] [Abstract][Full Text] [Related]
19. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(3):144-54. PubMed ID: 10392960
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cells as effector cells of graft-versus-leukemia activity in a murine transplantation model.
Uharek L; Glass B; Gaska T; Zeiss M; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S57-60. PubMed ID: 8124260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
